General Information of Drug Formulation (ID: F14879)

Formulation Name
Naproxen 250 mg tablet
Company
NCS HealthCare of KY, Inc dba Vangard Labs; Teva Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Naproxen DMZ5RGV Bursitis Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Eisenoxyd E00585 56841934 Colorant
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Magnesium stearate E00208 11177 lubricant